Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. | SVP, Chief Accounting Officer | Common Stock | 46.6K | $441K | $9.45 | Feb 24, 2025 | Direct |
Vir Biotechnology, Inc. | SVP, Chief Accounting Officer | Stock Option (Right to Buy) | 40K | $61.2K | $1.53 | Feb 22, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIR | Vir Biotechnology, Inc. | Feb 22, 2025 | 3 | -$14.8K | 4 | Feb 25, 2025 | SVP, Chief Accounting Officer |
VIR | Vir Biotechnology, Inc. | Feb 13, 2025 | 1 | -$14.3K | 4 | Feb 14, 2025 | SVP, Chief Accounting Officer |
VIR | Vir Biotechnology, Inc. | Oct 1, 2024 | 0 | $0 | 3 | Oct 2, 2024 | SVP, Chief Accounting Officer |